Celestial Biolab

CELESTIALBIOLABS11 Mar 2020

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Celestial Biolab

Celestial Biolab

Pharmaceuticals

CELESTIALBIOLABS11 Mar 2020

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
03-Aug-2009	D	Celestial Labs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 31, 2009, inter alia, have transacted the following business : The Board of Directors recommended a final dividend of Re 0.50 paise per share (5% on an equity share par value of Rs 10/- each).	23-Sep-2009
14-Jul-2008	D	Celestial Labs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 14, 2008, inter alia, has transacted the following: Recommended a dividend of 10% (ten percent only) on the paid-up share capital of Company subject to Approval of Members in Annual General Meeting.	07-Aug-2008
22-Apr-2024	BC	Board of Directors in their just concluded Board meeting held today have: Decided to convene the Twenty Fifth Annual General Meeting on 23.05.2024; To close the Register of members and share tr	23-May-2024
22-Apr-2024	BC	Annual General Meeting	21-May-2024
22-Apr-2024	BC	Board of Directors in their just concluded Board meeting held today have: 1. Recommended the reappointment of M Surendra & Associates, Chartered Accountants, Hyderabad (FRN No: 017280S) for a sec	22-Apr-2024
22-Apr-2024	BC	Board of Directors in their just concluded Board meeting held today have: Approved the appointment of Mr.Dattatreya Rao (DIN: 09719501) as Executive Director & Chief Executive Officer (CEO) of the	22-Apr-2024
23-Mar-2024	BC	Celestial Biolabs Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/03/2024 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of SE	29-Mar-2024

No Rights has been declared by CELESTIALBIOLABS

Book Closure

Record Date	Split Date	Purpose
23-May-2024	-	Board of Directors in their just concluded Board meeting held today have: Decided to convene the Twenty Fifth Annual General Meeting on 23.05.2024; To close the Register of members and share tr
21-May-2024	01 Jan'1900	Annual General Meeting
22-Apr-2024	-	Board of Directors in their just concluded Board meeting held today have: 1. Recommended the reappointment of M Surendra & Associates, Chartered Accountants, Hyderabad (FRN No: 017280S) for a sec
22-Apr-2024	-	Board of Directors in their just concluded Board meeting held today have: Approved the appointment of Mr.Dattatreya Rao (DIN: 09719501) as Executive Director & Chief Executive Officer (CEO) of the
29-Mar-2024	-	Celestial Biolabs Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/03/2024 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of SE

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Celestial Biolabs Ltd ₹1.75(0.00/0.00%)	1.75	+0.00	3.95	-70.83	0.00	1.72
Lupin Ltd ₹1,654.75(+7.10/0.43%)	1,654.75	+7.10	75,415.25	133.18	36.60	3.91
Ipca Laboratories Ltd ₹1,337.70(-13.30/-0.98%)	1,337.70	-13.30	33,938.01	88.94	61.57	5.46
J B Chemicals & Pharmaceuticals Ltd ₹1,889.90(+4.30/0.23%)	1,889.90	+4.30	29,330.27	80.31	57.90	10.92
Sanofi India Ltd ₹8,624.25(-53.50/-0.62%)	8,624.25	-53.50	19,861.65	59.17	33.61	19.54
IOL Chemicals & Pharmaceuticals Ltd ₹395.55(+3.25/0.83%)	395.55	+3.25	2,322.10	-0.40	13.44	1.46

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.04	0.04	0.02	0.04	0.03	0.04
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.04	0.04	0.02	0.04	0.03	0.04
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	0.04	0.04	0.02	0.04	0.03	0.04
Total Expenditure	0.07	0.06	0.12	0.27	0.18	0.12
PBIDT	-0.03	-0.03	-0.09	-0.23	-0.14	-0.07
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-0.03	-0.03	-0.09	-0.23	-0.15	-0.08
Depreciation	0.01	0.01	0.01	0.01	0.01	0.01
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.03	-0.03	-0.10	-0.24	-0.15	-0.08
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.03	-0.03	-0.10	-0.24	-0.15	-0.08

EPS (Unit Curr.)	-0.02	-0.01	-0.04	-0.10	-0.07	-0.04
EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Unit Curr.)	-0.02	-0.01	-0.04	-0.10	-0.07	-0.04
Calculated EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Ann.) (Unit Curr.)	-0.06	-0.06	-0.17	-0.42	-0.27	-0.15
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	22.59	22.59	22.59	22.59	22.59	22.59
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-75.00	-75.00	-450.00	-575.00	-466.67	-175.00
PBDTM(%)	-75.00	-75.00	-450.00	-575.00	-500.00	-200.00
PATM(%)	-75.00	-75.00	-500.00	-600.00	-500.00	-200.00

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.04	0.04	0.02	0.04	0.03	0.04
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.04	0.04	0.02	0.04	0.03	0.04
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	0.04	0.04	0.02	0.04	0.03	0.04
Total Expenditure	0.07	0.06	0.12	0.27	0.18	0.12
PBIDT	-0.03	-0.03	-0.09	-0.23	-0.15	-0.07
Interest	0.00	0.00	0.00	0.01	0.00	0.00
PBDT	-0.03	-0.03	-0.09	-0.24	-0.15	-0.07
Depreciation	0.01	0.01	0.01	0.01	0.01	0.01
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.04	-0.03	-0.10	-0.25	-0.15	-0.08
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	-0.04	-0.03	-0.10	-0.24	-0.15	-0.08

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.04	-0.03	-0.10	-0.24	-0.15	-0.08

EPS (Unit Curr.)	-0.02	-0.01	-0.04	-0.11	-0.07	-0.04
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	22.59	22.59	22.59	22.59	22.59	22.59

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-75.00	-75.00	-450.00	-575.00	-500.00	-175.00
PBDTM(%)	-75.00	-75.00	-450.00	-600.00	-500.00	-175.00
PATM(%)	-100.00	-75.00	-500.00	-625.00	-500.00	-200.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	22.59	22.59	22.59	22.59	22.59	22.59
Reserves Total	-19.81	-19.24	-18.83	-18.66	79.69	79.71
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	2.78	3.35	3.76	3.93	102.28	102.30
Secured Loans	0.00	0.00	0.00	0.00	0.00	4.60
Unsecured Loans	11.91	11.54	11.28	11.23	13.49	4.82
Total Debt	11.91	11.54	11.28	11.23	13.49	9.42
Total Liabilities	14.69	14.89	15.04	15.16	115.77	111.72
APPLICATION OF FUNDS :
Gross Block	12.77	12.76	12.76	12.76	111.33	103.47
Less : Accumulated Depreciation	12.69	12.66	12.63	12.59	59.81	50.37
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.08	0.10	0.13	0.17	51.52	53.10
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	12.82	12.82	12.82	12.82	45.24	29.56
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.03	0.05	0.05	0.05	6.14	3.96
Sundry Debtors	3.71	3.83	3.78	3.83	15.64	20.77
Cash and Bank	0.02	0.00	0.02	0.01	0.05	0.01
Loans and Advances	0.38	0.38	0.38	0.37	0.76	6.26
Total Current Assets	4.14	4.26	4.23	4.26	22.58	31.00
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	2.34	2.29	2.13	1.97	0.68	0.71
Provisions	0.00	0.00	0.00	0.11	1.48	1.55
Total Current Liabilities	2.34	2.29	2.13	2.08	2.16	2.26
Net Current Assets	1.79	1.97	2.10	2.18	20.42	28.73
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.13
Deferred Tax Liability	0.00	0.00	0.00	0.00	1.41	0.10
Net Deferred Tax	0.00	0.00	0.00	0.00	-1.41	0.03
Total Assets	14.69	14.89	15.04	15.16	115.76	111.42
Contingent Liabilities	1.29	1.29	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.00	0.02	0.01	0.05	0.01
Net Cash from Operating Activities	-0.35	-0.28	-0.03	-3.06	16.65
Net Cash Used In Investing Activities	-0.01	0.00	0.00	4.09	-18.66
Net Cash Used In Financing Activities	0.37	0.26	0.05	-1.07	2.05
Net Inc./Dec In Cash And Cash Equivalents	0.02	-0.02	0.01	-0.04	0.04
Cash And Cash Equivalents At End Of The Year	0.02	0.00	0.02	0.01	0.05

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

26.07%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

73.93%

**Promoter pledged shareholding 26.07%

About Celestial Biolabs Ltd

Celestial Biolabs Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 4.56 crores. It has reported a sales of Rs. 0.04 crores and a net profit of Rs. -0.03 crores for the quarter ended December 2018. The company management includes , A N Singh,Padma Singh,Jeetainder Roy Gour,Sada Naga Latha,Dattatreya Rao (Celestial Biolabs Ltd) among others.

Chairman

Registered office

Plot No 59 Road No 12,TSIIC Tech Park IDA Nacharam,Hyderabad,Telangana,500076

FAX :

Background

Incorporation Year1997

Face Value₹10

Market Lot1

How to buy Celestial Biolab shares on nse?

To buy Celestial Biolab shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Celestial Biolab share price today?

The Celestial Biolab shares price on nse is Rs.1.75 today.

What is the market cap of Celestial Biolab shares on NSE ?

The company has a market capitalization of Rs.3.95Cr

What is the PE & PB ratio of Celestial Biolab shares ?

PE is 0 and PB is 1.72

What is the 52 Week High and Low of Celestial Biolab shares?

Celestial Biolab stock price high: Rs.1.8 Celestial Biolab stock price low: Rs.0